Compare HRMY & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRMY | RNST |
|---|---|---|
| Founded | 2017 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 3.3B |
| IPO Year | 2020 | N/A |
| Metric | HRMY | RNST |
|---|---|---|
| Price | $37.78 | $36.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $51.33 | $43.17 |
| AVG Volume (30 Days) | ★ 695.1K | 540.9K |
| Earning Date | 11-04-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.54% |
| EPS Growth | ★ 50.44 | N/A |
| EPS | ★ 3.17 | 1.84 |
| Revenue | ★ $825,944,000.00 | $775,309,000.00 |
| Revenue This Year | $23.11 | $43.37 |
| Revenue Next Year | $16.15 | $13.13 |
| P/E Ratio | ★ $12.04 | $19.70 |
| Revenue Growth | ★ 21.13 | 13.04 |
| 52 Week Low | $25.52 | $26.97 |
| 52 Week High | $40.93 | $40.40 |
| Indicator | HRMY | RNST |
|---|---|---|
| Relative Strength Index (RSI) | 54.65 | 47.75 |
| Support Level | $37.12 | $36.84 |
| Resistance Level | $39.60 | $36.33 |
| Average True Range (ATR) | 1.15 | 0.65 |
| MACD | -0.38 | -0.15 |
| Stochastic Oscillator | 17.33 | 6.70 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.